Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2020-12-17 AGM Information
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(제22기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
AGM Information Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the 22nd Annual General Meeting (AGM) to determine shareholder voting rights. It is a brief notice (under 5,000 characters) announcing a procedural step for an upcoming meeting rather than the meeting materials themselves or a full report. Given it is a regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2020-12-17 Korean
기타시장안내(코스닥시장위원회 심의의결 결과 및 개선기간 부여 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding the KOSDAQ Market Committee's decision to grant an improvement period to Kolon TissueGene. It details regulatory actions, listing status, and future procedural requirements. Since it is a regulatory announcement regarding listing status and does not fit into specific categories like financial reports or shareholder voting, it falls under the general regulatory filing category.
2020-12-17 Korean
주권매매거래정지기간변경(개선기간 부여)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of trading for Kolon TissueGene, Inc. It details changes to the suspension period due to an extension of the improvement period granted by the exchange. As this is a regulatory announcement regarding trading status and does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-12-17 Korean
기타시장안내(코스닥시장위원회 개최 결과 및 심의속개 결정 안내)
Delisting Announcement Classification · 100% confidence The document is a short announcement from the Korea Exchange regarding the KOSDAQ Market Committee's decision to continue deliberations on the potential delisting of Kolon TissueGene. It is a regulatory notification regarding the status of a listing, not a formal delisting notice itself, and fits best under the general regulatory filing category.
2020-12-15 Korean
기타시장안내(코스닥시장위원회 개최 결과 및 심의속개 결정 안내)
Delisting Announcement Classification · 100% confidence The document is a short announcement from the KOSDAQ market regarding the status of Kolon TissueGene's listing review. It is not a full report, but rather a regulatory notification about a committee meeting outcome. Since it does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filing category.
2020-12-07 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Kolon TissueGene, Inc. for the period ending September 30, 2020. It contains detailed financial statements, management discussion, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.